What Actually Changed for Metastatic Disease? Kefah Mokbel on NCCN Breast Cancer v4.2026 Updates
Kefah Mokbel, Chair of Breast Cancer Surgery at London Breast Institute and Honorary Professor of Medicine at Cardiff University School of Medicine, shared a post on LinkedIn: “NCCN Breast Cancer…
Read the full articleYou might also wanna read
Ask HN: What is the latest on treatment of Metastatic Breast Cancer?
I was reading this recently shared post on the promise of CAR-T therapy for cancer[1]. However, it seems that it may not be universally appl
PBCC 2026: Breast Cancer CME Conference in Washington, D.C. (September 18-19)
September 18-19, 2026. Washington, D.C. Oncology CME conference for physicians, nurse practitioners, physician assistants, and oncology fell
Changing behavior to aid weight loss may be linked to reduced risks of obesity related cancers
A new systematic review and meta-analysis presented at the International Congress on Obesity (ICO2026), hosted by the World Obesity Federati
Safety of Breast-Conserving Surgery for Multifocal or Multicentric Breast Cancer
Conditions : Breast Cancer Interventions : Other: Breast-conserving surgery, postoperative radiotherapy and individualized adjuvant systemic
Los nuevos diagnósticos de cáncer no aumentaron como se anticipaba después de la pandemia
Aunque los nuevos diagnósticos de cáncer volvieron en gran parte a los niveles prepandémicos en 2021, no reflejan los diagnósticos ausentes
De-Escalation, Genomics and Multidisciplinary Care Redefines Breast Cancer Treatment
Amanda Amin, MD, Janice Lyons, MD and Alberto Montero, MD, explore the evolution of breast cancer treatment. The discussion highlights how p

Comments
Sign in to join the conversation.
No comments yet. Be the first.